Lytix Biopharma: Invitation to presentation of fourth quarter and second half 2022 results, Thursday 16 February
Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, will release its fourth quarter and second half 2022 results on Thursday, 16 February 2023 at 8am CEST. The results will be presented in a webcast with CEO Øystein Rekdal, CDO Graeme Currie and CFO Gjest Breistein at 2:30pm CEST.We encourage you to send us questions in advance, to be addressed during the Q&A session. Please send your email to post@lytixbiopharma.com. The presentation and subsequent Q&A session will be held in English and may be viewed live by registering here: https://forms.